Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebrospinal fluid
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 92 (1) , 9-15
- https://doi.org/10.1016/0022-510x(89)90171-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin‐2 levels in serum and cerebrospinal fluid of multiple sclerosis patientsAnnals of Neurology, 1988
- Elevated Levels of Soluble Interleukin-2 Receptors in Multiple SclerosisNew England Journal of Medicine, 1988
- Multiple sclerosis: Involvement of interferons in lesion pathogenesisAnnals of Neurology, 1988
- The Role of IL4 and IL5: Characterization of a Distinct Helper T Cell Subset that makes IL4 and IL5 (Th2) and Requires Priming before Induction of Lymphokine SecretionImmunological Reviews, 1988
- Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDSClinical Immunology and Immunopathology, 1987
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseasesClinical Immunology and Immunopathology, 1985
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Suppressor cell function in multiple sclerosis: Correlation with clinical disease activityAnnals of Neurology, 1979